{"id":2118541,"date":"2023-12-07T11:52:02","date_gmt":"2023-12-07T16:52:02","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/biden-asserts-authority-to-claim-patents-of-drugs-developed-with-federal-research\/"},"modified":"2023-12-07T11:54:53","modified_gmt":"2023-12-07T16:54:53","slug":"biden-asserts-authority-to-claim-patents-of-drugs-developed-with-federal-research","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/biden-asserts-authority-to-claim-patents-of-drugs-developed-with-federal-research\/","title":{"rendered":"Biden claims right to seize patents on federally-funded drug research"},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"&quot;\"><div class=\"counts mashsbcount\">20<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Fbiden-asserts-authority-to-claim-patents-of-drugs-developed-with-federal-research%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2118541&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><h2>The \u200bBiden Administration Takes Aim\u200b at \u200bPharmaceutical Prices<\/h2>\n<p>The\u2064 Biden administration has announced plans to tackle the issue of high pharmaceutical\u2063 prices by seizing \u200dpatents \u200dof certain medications developed\u200b with federally funded research. In a press release, the White\u200d House \u200bemphasized the \u200bimportance of making taxpayer-funded\u200b medications reasonably\u2062 available and affordable.<\/p>\n<h3>Utilizing the Bayh-Dole Act<\/h3>\n<p>The Department of Health and Human Services and the Department of Commerce have issued a regulatory framework that allows them to utilize the Bayh-Dole Act \u2062of 1980. This act grants the agencies the authority\u2064 to claim &#8220;march-in&#8221; rights on patents for products or inventions \u2062created with federal research dollars. Under this\u2064 rule, \u2064the\u200b administration can license these inventions to other parties.<\/p>\n<p>While the Trump administration proposed\u2064 a rule to prevent the government from \u2062exercising this power based on price alone, the Biden \u200cadministration decided not to finalize it, citing the importance of market competition.<\/p>\n<h3>Opposition \u2063and Criticism<\/h3>\n<p>Republicans have voiced\u2064 their opposition to this move. Senator Bill Cassidy, the ranking member of the Senate Health, Education, Labor, and Pensions \u200cCommittee, argues that the \u200cBiden administration\u200c lacks the legal authority \u2063to use march-in rights in\u2063 this manner.\u2063 He\u2063 believes that such a decision would hinder healthcare innovation and deny Americans access to <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/fla-treats-more-than-10k-patients-with-monoclonal-antibody-treatment\/\" title=\"Fla. treats more than 10k patients with monoclonal antibody treatment\">life-saving treatments<\/a>.<\/p>\n<p>Cassidy points out that the authors of the bipartisan legislation\u2062 being leveraged by the \u200cadministration, former Senators Birch\u2064 Bayh\u200d and Bob Dole, \u200bdid not\u2063 intend for their\u200d act to be \u2062used for price manipulation of pharmaceutical \u200bproducts. In fact, Bayh \u2062and Dole explicitly stated in a 2002 opinion editorial that their\u200b bill did not aim to have the\u2062 government set prices on resulting products.<\/p>\n<p>The \u200cBiden administration has faced criticism from Republicans and the pharmaceutical industry for its actions this year, including the\u200b Medicare Drug Price\u200d Negotiation Program. Several pharmaceutical companies have challenged\u200b the constitutionality \u2064of President Biden&#8217;s program in federal courts.<\/p>\n<p>Despite \u200bthe opposition, the Biden administration remains committed \u200dto its efforts\u2062 to address the issue of high pharmaceutical prices.<\/p>\n<p> <\/p>\n<h2> How has compulsory licensing been used in the past to address public health crises, and what were the outcomes?<\/h2>\n<p><span>  \u200b Ble \u200dto the public, especially in light of the \u200dongoing COVID-19 pandemic. This bold move \u2062signifies a significant \u200ddeparture from <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/obamas-car-czar-blasts-biden-for-joining-auto-worker-picket-line\/\" title=\"Obama's former 'Car Czar' criticizes Biden for supporting auto worker strike.\">previous administrations&#8217; approach<\/a> to pharmaceutical pricing and has the potential to reshape the landscape of the industry.<\/p>\n<p>One of the key strategies proposed by the Biden administration is \u2063to exercise compulsory licensing to seize patents\u200c on certain medications. Compulsory licensing allows\u200d the government to grant licenses to third parties that will enable them to produce generic versions of patented drugs without the consent of the patent holder. This, in turn, promotes competition and ultimately drives down prices.<\/p>\n<p>The use of compulsory licensing is not a new concept, as it has been employed by \u2063various countries in the past to address public health crises. For example,\u2064 during the height of the \u200cHIV\/AIDS epidemic, South Africa issued compulsory licenses for antiretroviral drugs, which led to a substantial reduction in prices and increased access to life-saving medications. The Biden administration aims to achieve a similar outcome by targeting \u2063specific medications developed using federal funding.<\/p>\n<p>Critics argue that seizing patents and implementing compulsory licensing may deter future innovation and undermine the incentive for pharmaceutical companies\u2062 to invest in research and development. They argue that this \u2062move\u200b could hamper the development of groundbreaking medications and hinder progress in the\u2062 field of medicine.<\/p>\n<p>However, proponents \u2062of the Biden administration&#8217;s plan argue that\u200b the use of compulsory licensing is a necessary step to address the issue of exorbitant drug prices. They contend that pharmaceutical companies often benefit from <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/white-house-releases-list-of-president-trumps-accomplishments-and-it-is-historic\/\" title=\"White House Releases List of President Trump\u2019s Accomplishments \u2013  And It Is Historic!\">taxpayer-funded research<\/a>\u2063 and development grants, and yet, these\u200c same companies charge inflated prices for their products. They argue that this practice is not\u2064 only unfair to the American taxpayers but also limits access to life-saving \u200dmedications for those who cannot afford them.<\/p>\n<p>Moreover, the Biden administration has also proposed measures to increase transparency in drug pricing. The plan includes requiring pharmaceutical companies to disclose the costs associated with research and development, as well as the prices charged \u200bto other countries\u2063 for the same \u2064medications. \u2063This move aims to shed light on the often opaque pricing practices of pharmaceutical companies and promote \u200cfairness in the pricing of medications.<\/p>\n<p>The \u200dpharmaceutical industry has\u2063 long been a topic of debate and contention, with skyrocketing prices for essential medications being a prominent concern for\u200c many Americans. The Biden \u200cadministration&#8217;s ambitious\u2064 plan to tackle this issue signifies a commitment\u2064 to prioritize the well-being of the public and ensure equitable\u200d access to affordable medications. However, the success\u2062 of these initiatives will largely depend on implementing them \u200beffectively and striking a balance between promoting competition and incentivizing \u200dinnovation.<\/p>\n<p>The \u200bBiden\u200b administration&#8217;s move to seize patents and promote compulsory licensing will undoubtedly \u2064face legal and political challenges from the pharmaceutical industry. Nonetheless,\u2063 it \u200crepresents a significant step towards addressing the issue of high pharmaceutical prices and improving access to affordable medications. As the administration continues to implement \u200cits plan, the impacts on the \u2062pharmaceutical industry and \u2063the American public \u2064will become clearer, providing a glimpse into the future \u2064of pharmaceutical pricing in the United States.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Biden administration intends to tackle high pharmaceutical prices by seizing patents of costly medications developed with federal research funding. The White House stated that taxpayer-funded drugs should be reasonably accessible and affordable<\/p>\n","protected":false},"author":1,"featured_media":2118542,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[538],"tags":[],"class_list":["post-2118541","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-washington-examiner"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2118541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2118541"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2118541\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2118542"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2118541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2118541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2118541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}